timothy sykes logo
IVF Stock Whipsaws Higher As Traders Zero In On Key Levels Thumbnail
G Google News

IVF Stock Whipsaws Higher As Traders Zero In On Key Levels

ELLIS HOBBS•UPDATED AUG. 17, 2026, 9:18 AM ET
Reviewed by Jack Kelloggand Fact-checked by Tim Sykes

INVO Fertility Inc. stocks have been trading up by 141.87 percent amid heightened optimism over its fertility treatment expansion plans.

Key Takeaways

  • IVF has ripped from sub-$1 closes on the daily chart to a volatile premarket range above $2, signaling aggressive day-trading interest.
  • The intraday IVF tape shows wide 5-minute candles, with sharp swings between $2 and above $3 that reward disciplined, plan-based trading.
  • INVO Fertility Inc. posts strong revenue growth but heavy losses, keeping IVF firmly in speculative territory.
  • IVF’s low price-to-sales and price-to-book ratios attract value-focused traders, while negative cash flow and weak liquidity flash clear risk.

Candlestick Chart

Live Update At 09:18:16 EDT: On Monday, August 17, 2026 INVO Fertility Inc. stock [NASDAQ: IVF] is trending up by 141.87%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

INVO Fertility Inc. is a classic high-risk, high-reward setup on paper. IVF generated about $6.8M in revenue over the last year, with revenue growth running hot — more than 90% over three years and almost 38% over five. That is strong top-line momentum for a micro-cap. But the rest of the income statement shows why traders treat IVF as a speculative trade, not a safe hold.

Profit margins are deep in the red. IVF’s EBIT margin sits around -115%, with return on equity and return on assets also sharply negative. The company is burning cash, with operating cash flow down about $1.9M in the latest quarter. IVF needed roughly $4.9M in financing cash flow to plug the hole.

More Breaking News

On the balance sheet, IVF holds about $4.9M in cash and total assets near $24.7M, against $9.6M in total liabilities. That keeps leverage moderate, but liquidity is tight with a current ratio under 1. For valuation, IVF trades around 0.31 times sales and 0.15 times book value, which draws bargain hunters but also signals the market’s concern over ongoing losses.

Why Traders Are Watching IVF Price Action

The chart is where IVF really comes to life for active traders. On the daily chart, INVO Fertility Inc. closed between $0.91 and $1.07 over the past couple of weeks, basically grinding sideways around the $1 handle. That kind of tight daily range can lull people to sleep. Then the intraday tape tells a completely different story.

Premarket 5-minute candles show IVF exploding from just above $1 at 04:00 to the low-$2s by 04:20, then spiking all the way toward $3.12 around 07:00 before fading back into the mid-$2s. Those are huge percentage swings packed into a few hours. IVF trading in that zone offers both massive opportunity and massive danger. A trader catching the move from around $2.00 to just over $3.00 would see a 40%+ push. Anyone chasing late without a stop could be underwater in minutes as IVF snaps back toward $2.40–$2.50.

The intraday action also shows repeated tests of the $2.50–$2.60 area, with IVF bouncing, failing, then trying again. That tells traders this band is a key short-term decision zone. If IVF can hold above it with volume, momentum traders will keep pressing the long side. If it loses that zone hard, short-biased traders will watch for a full round-trip back toward the $2 level or even closer to the earlier $1 range.

Because IVF is a low-priced, thinly capitalized name with big losses, the float likely reacts sharply to any surge in volume. That’s exactly the type of setup momentum traders seek: clear levels, wild range, and fast feedback when you’re right or wrong.

Conclusion

Put it all together and IVF looks like a pure trading vehicle right now. INVO Fertility Inc. has real revenue growth and decent gross margins, but deep net losses, negative operating cash flow, and a tight liquidity profile keep longer-term confidence low. That’s why IVF’s valuation ratios look cheap while the stock still behaves like a speculative rocket — the market demands a huge discount for taking on that risk.

For short-term traders, the game is simpler. IVF’s intraday swings from roughly $2 to above $3, against a daily base near $1, create a textbook volatility playground. The key is discipline. Map out support near $2 and resistance around the mid-$2s and low-$3s, then size small enough that a failed breakout or ugly wick doesn’t blow up your account. IVF rewards preparation and punishes hope. As millionaire penny stock trader and teacher Tim Sykes, says, “The goal is not to win every trade but to protect your capital and keep moving forward.” That mindset is crucial when navigating IVF’s sharp moves and noisy price action.

The balance sheet shows IVF has some runway but not endless room to burn cash, so any future fundamental shift could trigger another big re-pricing. Until then, IVF remains a technical and psychological test. As Tim Sykes likes to remind traders, “The market doesn’t care about your opinion, only your preparation and your discipline.” IVF is a live-fire example of that lesson every time it opens.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”